Abcellera Biologics shares owned by Duquesne Family Office
Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Duquesne Family Office
from 13F filings
Historical chart of Duquesne Family Office investment in Abcellera Biologics
Tip: Access up to 7 years of quarterly data
All positions including Abcellera Biologics held by Duquesne Family Office consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Abcellera Biologics by Duquesne Family Office
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $3.8M | 660k | 5.71 |
| 2023-09-30 | $3.0M | 660k | 4.60 |
| 2023-06-30 | $4.3M | 660k | 6.46 |
| 2023-03-31 | $5.0M | 660k | 7.54 |
| 2022-12-31 | $6.7M | 660k | 10.13 |
| 2022-09-30 | $6.5M | 660k | 9.89 |
| 2022-06-30 | $7.0M | 660k | 10.65 |
| 2022-03-31 | $6.4M | 660k | 9.75 |
| 2021-12-31 | $9.4M | 660k | 14.30 |
| 2021-09-30 | $13M | 660k | 20.04 |
| 2021-03-31 | $22M | 660k | 33.96 |
| 2020-12-31 | $27M | 660k | 40.24 |